AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Harte Hanks, Inc.

$4.3 +$1.24 (+40.52%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$4.2
Day Range
$4.24$4.38
Year Range
$2$4.5
Market Cap
31.9M
AVG Volume
96.63K
Trailing/Forward PE
-5.62/-
PEG ratio
0.03
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD)
0200M400M600M2016201720182019202020212022202320242025
HHS Revenue (USD) by year
PeriodRevenue (USD)
2025159.57M
2024185.24M
2023191.49M
2022206.28M
2021194.6M
2020176.9M
2019217.58M
2018284.63M
2017383.91M
2016415.57M
Net Income (USD)
-150M-100M-50M050M2016201720182019202020212022202320242025
HHS Net Income (USD) by year
PeriodNet Income (USD)
2025-811K
2024-30.3M
2023-1.57M
202236.78M
202114.97M
2020-1.69M
2019-26.26M
201817.18M
2017-41.86M
2016-130.94M
Operating Income (USD)
-60M-40M-20M020M2016201720182019202020212022202320242025
HHS Operating Income (USD) by year
PeriodOperating Income (USD)
20251.18M
20242.09M
20233.36M
202215.11M
20217.64M
2020-10.57M
2019-20.67M
2018-26.03M
2017-40.87M
2016-53.12M
EBITDA (USD)
-20M020M40M2016201720182019202020212022202320242025
HHS EBITDA (USD) by year
PeriodEBITDA (USD)
20254.25M
202410.59M
202313.08M
202221.55M
202119.72M
20202.41M
2019-17.91M
2018-16.96M
201738.66M
201635.37M
Cash Flows (USD)
-40M-20M020M40M2016201720182019202020212022202320242025
HHS Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-4.29M
2024-6.24M
20237.26M
202226.48M
2021-4.81M
2020-10.54M
20199.2M
2018-13.39M
2017-36.48M
20167.62M
EPS (USD)
-30-20-100102016201720182019202020212022202320242025
HHS EPS (USD) by year
PeriodEPS (USD)
2025-0.11
2024-4.17
2023-0.22
20224.75
20211.71
2020-0.44
2019-4.19
20182.25
2017-6.76
2016-21.25
Expenses (USD)
0100M200M300M400MSG&ACapex2016201720182019202020212022202320242025
HHS Expenses (USD) by year
PeriodExpenses (USD)
202585.41M
202496.12M
202392.97M
202271.01M
2021130.82M
2020127.9M
2019121.37M
2018202.28M
2017276.35M
2016306.75M
Cash & Debt (USD)
020M40M60MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
HHS Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20255.59M
20249.93M
202318.36M
202210.36M
202111.91M
202029.41M
201934.12M
201820.88M
20178.4M
201646.01M
Debt ratios
-2024620182019202020212022202320242025
HHS Debt ratios by year
PeriodDebt ratios
20250.34
20240.23
20230.18
20220.46
2021-1.48
20204.13
20190.13
2018-0.08
Margins
0%20%40%60%80%2016201720182019202020212022202320242025
HHS Margins by year
PeriodMargins
202541.2%
202464.16%
202358.17%
202244.61%
202174.17%
202072.14%
201951.72%
201864.78%
201771.58%
201671.75%
Return on Capital
-6000%-4000%-2000%0%2000%2016201720182019202020212022202320242025
HHS Return on Capital by year
PeriodReturn on Capital
2025-3.95%
2024-139.69%
2023-7.91%
2022195.53%
2021-99.86%
20203.9%
201965.73%
2018-181.61%
2017120.86%
2016-4929.86%
Shares Outstanding
02M4M6M8M2016201720182019202020212022202320242025
HHS Shares Outstanding by year
PeriodShares Outstanding
20257.39M
20247.36M
20237.22M
20227.27M
20216.98M
20206.58M
20196.23M
20186.25M
20176.2M
20166.14M
Dividends (USD)
02462007200820092010201120122013201420152016
HHS Dividends (USD) by year
PeriodDividends (USD)
20160.85
20153.4
20143.4
20132.55
20124.25
20113.2
20103
20093
20083
20072.8
Employee Count
02K4K6K2016201720182019202020212022202320242025
HHS Employee Count by year
PeriodEmployee Count
20251.72K
20241.72K
20231.71K
20221.88K
20211.94K
20201.83K
20191.94K
20182.82K
20175.39K
20165.59K
Book Value Per Share (USD)
-7.5-5-2.502.552016201720182019202020212022202320242025
HHS Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20252.78
20242.95
20232.75
20222.59
2021-2.15
2020-6.6
2019-6.41
2018-1.51
2017-5.58
20160.43
Total Assets (USD)
0100M200M300M2016201720182019202020212022202320242025
HHS Total Assets (USD) by year
PeriodTotal Assets (USD)
202591.83M
2024101.78M
2023131.07M
2022119.98M
2021107.86M
2020119.5M
2019115.47M
2018125.17M
2017130.81M
2016213.44M
PE Ratio
0246810med 2.54Jul 22Oct 22Feb 23May 23Sep 23Dec 23Mar 24
HHS PE Ratio by year
PeriodPE Ratio
Mar 242.44
Mar 242.46
Mar 242.49
Mar 242.46
Mar 242.52
Feb 242.56
Feb 242.55
Feb 242.56
Feb 242.49
Jan 242.52
Jan 242.49
Jan 242.41
Jan 242.32
Dec 232.21
Dec 232.28
Dec 232.35
Dec 232.29
Dec 232.38
Nov 232.19
Nov 232.3
Nov 231.77
Nov 231.78
Oct 231.57
Oct 231.51
Oct 231.47
Oct 231.66
Sep 231.67
Sep 231.58
Sep 231.59
Sep 231.59
Sep 231.64
Aug 231.65
Aug 231.46
Aug 231.46
Aug 231.33
Jul 231.3
Jul 231.24
Jul 231.18
Jul 231.19
Jun 231.25
Jun 231.26
Jun 231.39
Jun 231.42
Jun 231.36
May 231.35
May 231.2
May 231.31
May 231.2
Apr 231.67
Apr 231.69
Apr 231.72
Apr 231.71
Mar 231.86
Mar 233.78
Mar 234.03
Mar 234.08
Mar 234.64
Feb 234.47
Feb 234.72
Feb 234.61
Feb 234.87
Jan 235.03
Jan 235.69
Jan 235.75
Jan 235.14
Dec 224.96
Dec 224.88
Dec 225.15
Dec 224.78
Dec 224.7
Nov 224.43
Nov 224.38
Nov 225.14
Nov 225.24
Oct 226.01
Oct 225.36
Oct 225.51
Oct 225.42
Sep 225.6
Sep 225.25
Sep 226.11
Sep 227.54
Sep 227.21
Aug 228.09
Aug 228.67
Aug 227.7
Aug 224.13
Jul 224.53
Jul 224.43
Jul 224.23
Jul 224.32
Jul 224.38
Jun 223.67
Jun 223.52
Jun 223.78
Jun 223.29
May 222.99
May 222.92
May 222.92
May 223.72
Free Cash Flow Yield
-40%-30%-20%-10%0%med -17.82%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
HHS Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-4.48%
Sep 26-4.58%
Sep 26-4.51%
Aug 26-4.43%
Aug 26-5.23%
Aug 26-4.48%
Aug 26-25.26%
Jul 26-26.3%
Jul 26-24.1%
Jul 26-23.6%
Jul 26-23.13%
Jul 26-25.6%
Jun 26-27.82%
Jun 26-24%
Jun 26-22.76%
Jun 26-22.67%
May 26-23.04%
May 26-21.98%
May 26-20.57%
May 26-20.58%
May 26-21.18%
Apr 26-21.03%
Apr 26-20.08%
Apr 26-24.59%
Apr 26-23.22%
Mar 26-24.49%
Mar 26-22.5%
Mar 26-0.91%
Mar 26-0.91%
Feb 26-0.92%
Feb 26-0.89%
Feb 26-0.9%
Feb 26-0.86%
Jan 26-0.84%
Jan 26-0.82%
Jan 26-0.82%
Jan 26-0.86%
Jan 26-0.83%
Dec 25-0.76%
Dec 25-0.75%
Dec 25-0.79%
Dec 25-0.79%
Nov 25-0.67%
Nov 25-0.88%
Nov 25-0.85%
Nov 25-35.39%
Oct 25-31.52%
Oct 25-28.33%
Oct 25-28.01%
Oct 25-27%
Oct 25-27%
Sep 25-26.49%
Sep 25-26.42%
Sep 25-25.73%
Sep 25-26.71%
Aug 25-27.23%
Aug 25-26.78%
Aug 25-26.56%
Aug 25-26.64%
Aug 25-4.41%
Jul 25-4.38%
Jul 25-4.48%
Jul 25-3.9%
Jul 25-4.09%
Jun 25-3.8%
Jun 25-3.93%
Jun 25-3.65%
Jun 25-3.46%
May 25-3.31%
May 25-3.17%
May 25-3.33%
May 25-18.75%
May 25-16.95%
Apr 25-18.23%
Apr 25-18.19%
Apr 25-18.43%
Apr 25-17.69%
Mar 25-18.15%
Mar 25-17.73%
Mar 25-19.27%
Mar 25-18.93%
Feb 25-18.78%
Feb 25-19%
Feb 25-18.24%
Feb 25-17.74%
Jan 25-17.8%
Jan 25-18.07%
Jan 25-18.49%
Jan 25-18.45%
Jan 25-17.87%
Dec 24-17.84%
Dec 24-17.74%
Dec 24-16.54%
Dec 24-16.18%
Nov 24-16.43%
Nov 24-16.32%
Nov 24-14.99%
Nov 24-1.72%
Nov 24-1.67%
Oct 24-1.64%
Price to Sales
0.050.10.150.20.250.3med 0.15Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
HHS Price to Sales by year
PeriodPrice to Sales
Sep 260.21
Sep 260.2
Sep 260.21
Aug 260.21
Aug 260.18
Aug 260.21
Aug 260.11
Jul 260.1
Jul 260.11
Jul 260.12
Jul 260.12
Jul 260.11
Jun 260.1
Jun 260.11
Jun 260.12
Jun 260.12
May 260.12
May 260.13
May 260.13
May 260.13
May 260.13
Apr 260.13
Apr 260.13
Apr 260.11
Apr 260.12
Mar 260.11
Mar 260.12
Mar 260.12
Mar 260.12
Feb 260.12
Feb 260.13
Feb 260.12
Feb 260.13
Jan 260.13
Jan 260.14
Jan 260.14
Jan 260.13
Jan 260.14
Dec 250.15
Dec 250.15
Dec 250.14
Dec 250.14
Nov 250.17
Nov 250.13
Nov 250.13
Nov 250.12
Oct 250.13
Oct 250.15
Oct 250.15
Oct 250.15
Oct 250.15
Sep 250.16
Sep 250.16
Sep 250.16
Sep 250.15
Aug 250.15
Aug 250.15
Aug 250.16
Aug 250.16
Aug 250.14
Jul 250.14
Jul 250.14
Jul 250.16
Jul 250.15
Jun 250.16
Jun 250.16
Jun 250.17
Jun 250.18
May 250.18
May 250.19
May 250.18
May 250.18
May 250.2
Apr 250.18
Apr 250.19
Apr 250.18
Apr 250.19
Mar 250.19
Mar 250.19
Mar 250.19
Mar 250.2
Feb 250.2
Feb 250.2
Feb 250.21
Feb 250.21
Jan 250.21
Jan 250.21
Jan 250.2
Jan 250.2
Jan 250.21
Dec 240.21
Dec 240.21
Dec 240.23
Dec 240.23
Nov 240.23
Nov 240.23
Nov 240.25
Nov 240.27
Nov 240.28
Oct 240.28
EV/EBITDA
246810med 5.01Nov 24Feb 25Jun 25Sep 25Jan 26Apr 26Aug 26
HHS EV/EBITDA by year
PeriodEV/EBITDA
Aug 268.84
Jul 268.67
Jul 269.05
Jul 269.14
Jul 269.24
Jul 268.78
Jun 268.44
Jun 269.07
Jun 269.31
Jun 269.33
May 269.26
May 269.49
May 269.83
May 268.87
May 268.73
Apr 268.76
Apr 268.99
Apr 268.07
Apr 268.31
Mar 268.09
Mar 268.45
Mar 265.46
Mar 265.46
Feb 265.42
Feb 265.52
Feb 265.49
Feb 265.63
Jan 265.74
Jan 265.82
Jan 265.82
Jan 265.64
Jan 265.77
Dec 256.07
Dec 256.11
Dec 255.92
Dec 255.94
Nov 256.57
Nov 255.57
Nov 255.68
Nov 254.41
Oct 254.7
Oct 255
Oct 255.03
Oct 255.14
Oct 255.14
Sep 255.2
Sep 255.21
Sep 255.29
Sep 255.17
Aug 255.11
Aug 255.17
Aug 255.19
Aug 255.18
Aug 253.88
Jul 253.9
Jul 253.84
Jul 254.2
Jul 254.07
Jun 254.27
Jun 254.18
Jun 254.39
Jun 254.55
May 254.7
May 254.84
May 254.67
May 254.53
May 254.86
Apr 254.62
Apr 254.62
Apr 254.58
Apr 254.71
Mar 254.63
Mar 254.71
Mar 253.63
Mar 253.68
Feb 253.7
Feb 253.67
Feb 253.77
Feb 253.84
Jan 253.83
Jan 253.79
Jan 253.73
Jan 253.74
Jan 253.82
Dec 243.82
Dec 243.84
Dec 244.02
Dec 244.09
Nov 244.04
Nov 244.06
Nov 244.31
Nov 244.39
Nov 244.49
Oct 244.54
Oct 244.53
Oct 244.62
Oct 244.35
Sep 244.55
Sep 244.63
Sep 244.68
Price/Operating Cashflow
0102030med 12.51Oct 23Feb 24May 24Sep 24Jun 25Jan 26Sep 26
HHS Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 2624.49
Sep 2623.92
Sep 2624.31
Aug 2624.71
Aug 2620.95
Aug 2624.49
Mar 2611.57
Mar 2611.57
Feb 2611.45
Feb 2611.82
Feb 2611.7
Feb 2612.2
Jan 2612.62
Jan 2612.91
Jan 2612.91
Jan 2612.24
Jan 2612.74
Dec 2513.82
Dec 2513.99
Dec 2513.28
Dec 2513.36
Nov 2515.7
Nov 2511.99
Nov 2512.41
Aug 2511.32
Jul 2511.42
Jul 2511.15
Jul 2512.81
Jul 2512.22
Jun 2513.15
Jun 2512.71
Jun 2513.68
Jun 2514.44
May 2515.11
May 2515.77
May 2515.01
Nov 2426.74
Nov 2427.51
Oct 2427.93
Oct 2427.89
Oct 2428.55
Oct 2426.44
Sep 2428.05
Sep 2428.62
Sep 2429.08
Sep 2428.09
Aug 2428.85
Aug 2428.89
Aug 2428.2
Aug 2427.47
Aug 2421.36
Jul 2421.61
Jul 2421.26
Jul 2421.44
Jul 2422.23
Jun 2420.7
Jun 2419.68
Jun 2419.8
Jun 2418.68
May 2418.68
May 2418.84
May 2419.32
May 2417.82
May 245.1
Apr 245.13
Apr 245.01
Apr 245.01
Apr 245.01
Mar 243.36
Mar 243.38
Mar 243.43
Mar 243.39
Mar 243.47
Feb 243.52
Feb 243.51
Feb 243.52
Feb 243.43
Jan 243.46
Jan 243.43
Jan 243.31
Jan 243.19
Dec 233.05
Dec 233.15
Dec 233.23
Dec 233.15
Dec 233.28
Nov 233.02
Nov 233.17
Nov 231.88
Nov 231.89
Oct 231.67
Oct 231.61
Oct 231.56
Oct 231.77
Sep 231.77
Sep 231.68
Sep 231.7
Sep 231.69
Sep 231.75
Aug 231.76
Price to Book
0.511.522.53med 1.23Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
HHS Price to Book by year
PeriodPrice to Book
Sep 262.08
Sep 262.03
Sep 262.07
Aug 262.1
Aug 261.78
Aug 262.08
Aug 260.84
Jul 260.81
Jul 260.88
Jul 260.9
Jul 260.92
Jul 260.83
Jun 260.76
Jun 260.89
Jun 260.93
Jun 260.94
May 260.92
May 260.97
May 261.03
May 261.02
May 260.99
Apr 260.99
Apr 261.04
Apr 260.85
Apr 260.9
Mar 260.85
Mar 260.93
Mar 261.03
Mar 261.03
Feb 261.02
Feb 261.06
Feb 261.04
Feb 261.09
Jan 261.13
Jan 261.15
Jan 261.15
Jan 261.09
Jan 261.14
Dec 251.23
Dec 251.25
Dec 251.19
Dec 251.19
Nov 251.4
Nov 251.07
Nov 251.11
Nov 250.92
Oct 251.03
Oct 251.15
Oct 251.16
Oct 251.2
Oct 251.2
Sep 251.23
Sep 251.23
Sep 251.26
Sep 251.22
Aug 251.19
Aug 251.21
Aug 251.22
Aug 251.22
Aug 251.17
Jul 251.18
Jul 251.15
Jul 251.33
Jul 251.26
Jun 251.36
Jun 251.32
Jun 251.42
Jun 251.49
May 251.56
May 251.63
May 251.55
May 251.53
May 251.7
Apr 251.58
Apr 251.58
Apr 251.56
Apr 251.62
Mar 251.58
Mar 251.62
Mar 251.73
Mar 251.76
Feb 251.78
Feb 251.76
Feb 251.83
Feb 251.88
Jan 251.88
Jan 251.85
Jan 251.81
Jan 251.81
Jan 251.87
Dec 241.87
Dec 241.88
Dec 242.02
Dec 242.06
Nov 242.03
Nov 242.05
Nov 242.23
Nov 242.46
Nov 242.53
Oct 242.57
Harte Hanks, Inc.
HHS
Stockpicker

Video analysis: HHS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: HHS

HHS plans new FDA deputy commissioner roles for technology and drugs, sources say

cnbc.com · 25 Aug 2026

HHS plans new FDA deputy commissioner roles for technology and drugs, sources say

The Department of Health and Human Services is planning to appoint deputy commissioners for technology and drugs at the FDA, creating new roles at the agency, CNBC has learned. Like existing deputy commissioner roles, the two new positions would report into Trump's pick for FDA commissioner, Heidi Overton, who still needs to be confirmed by the Senate.

$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX

gurufocus.com · 23 Aug 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX

$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX PR Newswire

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

gurufocus.com · 17 Aug 2026

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 17, 2026

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

prnewswire.com · 17 Aug 2026

Are MITT, ARX, HHS, FULC Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

Shareholder Alert: Ademi LLP investigates whether Harte Hanks, Inc. is obtaining a Fair Price for Public Shareholders

prnewswire.com · 14 Aug 2026

Shareholder Alert: Ademi LLP investigates whether Harte Hanks, Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE, Aug. 14, 2026 /PRNewswire/ -- Ademi LLP is investigating Harte Hanks (NASDAQ: HHS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Star Equity. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.

HHS Stock Alert: Halper Sadeh LLC is Investigating Whether Harte Hanks, Inc. is Obtaining a Fair Price for its Shareholders

businesswire.com · 14 Aug 2026

HHS Stock Alert: Halper Sadeh LLC is Investigating Whether Harte Hanks, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Harte Hanks, Inc. (NASDAQ: HHS) to Star Equity Holdings, Inc. Under the terms of the proposed transaction, Harte Hanks shareholders may elect to receive either (1) $5.00 in cash for each Harte Hanks share, or (2) 0.50 shares of Star Equity's publicly traded 10% Series A Cumulative Perpetual Preferred Stock for each Harte Hanks share. Halper Sadeh encourages Harte Hanks shareholders to click he.

Star Equity Holdings Enters Into Merger Agreement to Acquire Harte Hanks

globenewswire.com · 14 Aug 2026

Star Equity Holdings Enters Into Merger Agreement to Acquire Harte Hanks

Transaction Expands Star's Business Services Platform, Enhances Revenue Diversity, and is Expected to Drive Significant Cost Synergies and Earnings Accretion  Harte Hanks Stockholders to Receive $5.00 per Share, Consisting of Cash and Star Preferred Stock OLD GREENWICH, Conn., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (“Star”) (Nasdaq: STRR; STRRP), a diversified holding company, announced today that it has entered into a merger agreement (the “Merger Agreement”) to acquire Harte Hanks, Inc. (the “Merger”) (“Harte Hanks”) (Nasdaq: HHS), a global customer experience and business process outsourcing company (together with Star, the “Companies”).

Harte Hanks Enters Definitive Agreement to Be Acquired by Star Equity Holdings for $5.00 Per Share

accessnewswire.com · 14 Aug 2026

Harte Hanks Enters Definitive Agreement to Be Acquired by Star Equity Holdings for $5.00 Per Share

Transaction Represents an Approximately 100% Premium to Harte Hanks' Unaffected Share Price Harte Hanks Shareholders to Receive 50% Cash and 50% in Star Equity 10% Preferred Stock CHELMSFORD, MA / ACCESS Newswire / August 14, 2026 / Harte Hanks, Inc. (NASDAQ:HHS) ("Harte Hanks" or the "Company") and Star Equity Holdings, Inc. (NASDAQ:STRR)(NASDAQ:STRRP) ("Star Equity") today announced they have entered into a definitive merger agreement under which Star Equity will acquire all outstanding shares of Harte Hanks common stock for $5.00 per share, or $38.4 million in aggregate equity value. The Harte Hanks Board of Directors unanimously approved the transaction and recommends Harte Hanks shareholders vote in favor of the transaction.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.